Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Exercises Licensing Option on Cold-PCR Technology

NEW YORK (GenomeWeb News) – Transgenomic today said that it has completed an option to license from the Dana-Farber cancer Institute a method known as Cold-PCR, which is a variation of standard PCR technology that enriches mutations in samples where normal DNA predominates.

The technology was developed by a Dana-Farber researcher, who demonstrated that it could enrich mutations in cancer-related genes in samples where DNA sequencing cannot detect very low concentrations of somatic DNA mutation, said Transgenomic. The Omaha, Neb.-based firm said that the technology could potentially enable clinicians to use less intrusive methods for genetic analysis or allow for more efficient use of tumor tissue samples.

"Cold-PCR has the potential to further increase the sensitivity of Transgenomic's WAVE DHPLC and Surveyor Nuclease products for mutation detection in cancer and mitochondrial diseases," said Eric Kaldjian, CSO of Transgenomic, in a statement. "In combination, Cold-PCR and WAVE/Surveyor have the potential to detect one mutant copy of DNA out of a thousand to as many as ten thousand normal copies."

Financial and other terms of the license were not disclosed.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.